• Contact us
  • FAQs
AlmirallShare
  • About us
  • Collaboration Opportunities
  • What we offer
  • In numbers
  • News
  • Login
  • About us
  • Collaboration Opportunities
  • What we offer
  • In numbers
  • News
  • Contact us
  • FAQs
AlmirallShare
Login AlmirallShare

Home > Almirall calls for new therapies to treat skin diseases

Published on 22/07/2020

Almirall calls for new therapies to treat skin diseases

AlmirallShare launches its fifth call for proposals to identify new assets for the treatment of dermatological conditions

AlmirallShare, the open innovation platform of Almirall, S.A. (ALM), launches its fifth call, aiming to establish collaborations in dermatological research and identify new treatments for skin health. The call seeks partnering opportunities for new assets—new chemical entities, biologics and other advanced therapies—in order to maximize their value as innovative therapies. With this call to the scientific community, Almirall opts once again to unite the science and creativity of experts from around the world with the company’s knowledge and expertise.

Assets submitted for consideration must be in late research or preclinical development stages, address a specific pathway, and demonstrate a therapeutic potential for treating dermatological conditions.

Innovative therapies for skin diseases

Maximising the value of your preclinical assets to find a breakthrough therapy for patients.

Read More

AlmirallShare is responsible for approximately 50% of the private-public collaborations driven by Almirall. Since its launch in 2017, more than 900 scientists have shown interest in participating and more than 350 proposals have been received. To date, six collaborations have been established, based on new therapies (IDIBAPS, University of Turin), new targets (Dublin City University, University of Namur), and new preclinical models (University College Dublin, University of Sheffield). Additionally, three new collaborative projects are expected to start very soon.

With this fifth call, AlmirallShare reinforces its commitment to collaborative and shared innovation in R&D by offering a partnership opportunity and asset characterisation conducted by Almirall in a pre-agreed panel of relevant cellular assays and in vivo models of dermatological diseases. In all cases, applicants will retain ownership of their intellectual property.

Scientists affiliated with start-ups, biotechs, universities, research centres, and pharmaceutical companies from anywhere in the world may submit their proposals on sharedinnovation.almirall.com from July 22, 2020 to October 31, 2020. Terms and conditions can be found on the website.

‘’AlmirallShare calls were very well received by the scientific community. This encourages us to continue promoting new partnership projects in R&D to develop innovative solutions in medical dermatology. After having started what looks to be very promising collaborative projects since 2017, AlmirallShare has become a key tool for successful strategic partnerships that will translate into advances in treatments for dermatological conditions,” said Maribel Crespo, AlmirallShare leader.

For more information, please visit almirall.com


Tags: Almirall, AlmirallShare, asset, collaboration in dermatology, dermatological research, Innovation, skin diseases, therapies

Related News

Published on 24/11/2020

New AlmirallShare partnerships

Almirall started research collaborations with the University of South Australia and Hospital de la Santa Creu i Sant Pau

Read More
Published on 02/01/2020

AlmirallShare provides for 50% of Almirall’s public-private partnerships

Four new collaborations in 2019 with Dublin City University, IDIBAPS in Barcelona, University of Turin, and University of Namur.

Read More

Related News

Published on 24/11/2020

New AlmirallShare partnerships

Almirall started research collaborations with the University of South Australia and Hospital de la Santa Creu i Sant Pau

Read More
Published on 02/01/2020

AlmirallShare provides for 50% of Almirall’s public-private partnerships

Four new collaborations in 2019 with Dublin City University, IDIBAPS in Barcelona, University of Turin, and University of Namur.

Read More
Published on 22/07/2019

Immune-inflammatory diseases under your skin, AlmirallShare new call

We aim to establish collaborations to find innovative targets, pathways or therapies in medical dermatology.

Read More

Almirall calls for new therapies to treat skin diseases

Share

Post navigation

 AlmirallShare provides for 50% of Almirall’s public-private partnershipsResearch collaboration with University of Dundee 
AlmirallShare

Science Partner

  • About us
  • Collaboration Opportunities
  • What we offer
  • In numbers
  • News
  • FAQs
Get in Touch

Any questions or comments about opportunities for collaboration?

Contact Us

© 2020 AlmirallShare
Jul 2020 | HQ-NOP-2000139

  • Terms of use
  • Privacy Policy
  • Cookies Policy